New Cancer Research Seen Leading to Better Screening, Potential New Drugs

New research has nearly doubled the number of genetic variations implicated in breast, prostate and ovarian cancer, offering fresh avenues for screening at-risk patients and, potentially, developing better drugs.
      
The bumper haul of 74 gene changes that can increase risks for the three hormone-related cancers, announced by scientists on Wednesday, is the result of the largest ever study of its kind.
      
It follows an … [Read More]

—–
Source: VOA News: War and Conflict


« Previous Post
Next Post »
 

Comments are closed. Please check back later.

 
 
 
1